VRTX
Vertex Pharmaceuticals Inc
$527.00
3.81 (0.73%) Today
0.81 (0.15%) After-hours
— up— down
Market Cap
$121.09B+36.4%
Revenue (TTM)
$12.52B+10.2%
Net Income (TTM)
$4.36B+22.5%
EPS (TTM)
17.19+22.5%
Shares Out
253.81M
253.81MP/E Ratio
30.41
30.41Forward P/E
25.19
25.19Open
$526.19
$526.19Previous Close
$522.38
$522.38Day Range
$518.92 – $527.69
$518.92 – $527.6952-Week Range
$384.39 – $560.25
$384.39 – $560.25Beta
0.28
0.28Volume
756.21K
756.21KAvg Volume
1.40M
1.40MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout VRTX
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.
Related
News
N/AN/AN/AN/AN/A
Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know
Yahoo · 3d ago
Will Vertex's Kidney Disease Pipeline Be a New Growth Engine?
Yahoo · 3d ago
CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo · 3d ago
Vertex (VRTX) Stock Could Be 24% Undervalued As Kidney Trial Progress Continues
Yahoo · 3d ago
Vertex Posts Positive Phase II Data on Kidney Disease Drug
Yahoo · 4d ago